A Trial of Gemtuzumab Ozogamicin (GO) in Combination With Zosuquidar in Patients With CD33 Positive Acute Myeloid Leukemia
Clinical trial NCT00233909 · COMPLETED
Trial details
- NCT number
- NCT00233909
- Sponsor
- Kanisa Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Primary completion
- 2008-03-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.